What is the equivalent dosage of dexamphetamine (Dextroamphetamine) when converting from Lisdexamphetamine (Vyvanse)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lisdexamfetamine to Dexamphetamine Conversion

Direct Conversion Formula

When converting from lisdexamfetamine (Vyvanse) to dexamphetamine (Dextroamphetamine), use a conversion ratio of approximately 0.3, meaning 100 mg of lisdexamfetamine yields approximately 30 mg of active dexamphetamine. 1, 2

Conversion Calculation

  • For every 100 mg of lisdexamfetamine, expect approximately 30 mg of active dexamphetamine to be released systemically 2
  • The conversion is based on the molecular weight difference and the fact that lisdexamfetamine is a prodrug that must be hydrolyzed to release active dexamphetamine 1, 2
  • Example: A patient on lisdexamfetamine 70 mg would convert to approximately 21 mg of dexamphetamine equivalents 2

Practical Dosing After Conversion

Start with 70-75% of the calculated equivalent dose when switching from lisdexamfetamine to immediate-release dexamphetamine, then titrate by 2.5-5 mg increments weekly based on response. 3, 4

Specific Conversion Examples:

  • Lisdexamfetamine 30 mg → Start dexamphetamine 7.5 mg total daily (split as 2.5 mg TID or 5 mg BID) 3, 4
  • Lisdexamfetamine 50 mg → Start dexamphetamine 10-12.5 mg total daily (split as 5 mg BID or 5 mg TID) 3, 4
  • Lisdexamfetamine 70 mg → Start dexamphetamine 15 mg total daily (split as 5 mg TID or 7.5 mg BID) 3, 4

Dosing Schedule Options

  • For twice-daily dosing: Give the total daily dose split evenly in morning and early afternoon (before 2 PM) 3, 4
  • For three-times-daily dosing: Split the total daily dose into morning, midday, and early afternoon doses for more consistent coverage 3, 4
  • Consider dexamphetamine Spansule (extended-release) once daily in the morning if available, using the calculated total daily dose 3, 4

Critical Pharmacokinetic Differences

  • Lisdexamfetamine has a delayed Tmax of approximately 3.5 hours for active dexamphetamine versus 1 hour for immediate-release dexamphetamine 2, 5
  • The lag time for lisdexamfetamine is approximately 1 hour longer than immediate-release dexamphetamine 5
  • Immediate-release dexamphetamine will have a faster onset (within 30-60 minutes) and shorter duration (4-6 hours per dose) compared to lisdexamfetamine's 13-14 hour duration 6, 5
  • Peak plasma concentrations occur earlier with immediate-release dexamphetamine, which may increase side effects initially 5

Titration and Monitoring Protocol

  • Allow at least one week between dose adjustments to properly evaluate response 3, 4
  • Titrate in 2.5-5 mg increments based on symptom control and tolerability 3, 4
  • Maximum recommended daily dose is 40-50 mg for dexamphetamine 3, 4, 7
  • Monitor blood pressure and pulse at baseline and with each dose adjustment 4
  • Weigh patient at each visit to monitor for appetite suppression 4

Common Pitfalls to Avoid

  • Do not give late afternoon or evening doses—last dose should be before 2-3 PM to minimize sleep disturbances 4
  • Do not exceed maximum recommended doses (40-50 mg/day) if inadequate response occurs—instead reassess diagnosis and consider switching to methylphenidate or non-stimulant alternatives 3, 4, 7
  • Patients may initially report decreased duration of effect compared to lisdexamfetamine, which is expected given the shorter half-life of immediate-release formulations 6, 5
  • Approximately 70% of patients respond to a single stimulant type, but nearly 90% respond if both amphetamine and methylphenidate are tried 3, 4

Special Considerations for Immediate-Release Formulations

  • The faster onset and offset of immediate-release dexamphetamine may cause more noticeable "peaks and valleys" in symptom control compared to lisdexamfetamine 6, 5
  • Some patients may require a third afternoon dose to maintain coverage through homework or work hours 3, 4
  • For children weighing less than 25 kg, single doses should generally not exceed 15 mg 3, 7

References

Research

Lisdexamfetamine.

Paediatric drugs, 2007

Guideline

practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry, 2002

Guideline

Amphetamine Dose Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Recommended Doses of Adderall XR and IR for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dosing when switching from Vyvanse (lisdexamfetamine) 70mg to Mydayis (mixed salts of a single-entity amphetamine product)?
What is the safe protocol to switch an adult patient taking Adderall (mixed‑amphetamine salts) 10 mg twice daily to Vyvanse (lisdexamfetamine), including appropriate wash‑out period, starting dose, contraindications, and monitoring parameters?
What is the equivalent dose of Adderall (mixed‑amphetamine salts) for Vyvanse (lisdexamfetamine) 30 mg?
Do adults who metabolize amphetamine quickly (e.g., on 25 mg Adderall XR) respond better to Vyvanse (lisdexamfetamine)?
What is the equivalent dose of Vyvanse (lisdexamfetamine) for a patient taking Adderall (amphetamine and dextroamphetamine) 15mg three times a day (TID)?
What are the risks and management strategies for creatine kinase (CK) elevation associated with Cabenuva (cabotegravir and rilpivirine)?
What is the treatment for low output heart failure?
What is a suitable titration schedule for restarting Mounjaro (tirzepatide) in a patient who previously tolerated 5mg for a month, after a one-month discontinuation, with the goal of reaching 15mg while away for 4 months?
Do FSH (Follicle-Stimulating Hormone) and LH (Luteinizing Hormone) lab tests need to be collected at a certain time?
What could be causing right-sided abdominal pain triggered by drinking water, accompanied by nausea, but no symptoms when eating?
What is the proper usage and dosage of PT-141 (bremelanotide) for treating hypoactive sexual desire disorder and erectile dysfunction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.